Loading clinical trials...

Double Blind, Randomized Trial of Bosentan for Sarcoidosis Associated Pulmonary Hypertension | Clinical Trials | Clareo Health

Back to clinical trial search

COMPLETEDPhase 2/3NCT00581607

Double Blind, Randomized Trial of Bosentan for Sarcoidosis Associated Pulmonary Hypertension

Patients with advanced sarcoidosis often develop pulmonary hypertension. Pulmonary hypertension is a condition where the right side of the heart has to push the blood though the lungs at a higher pres...

Lead sponsor: University of Cincinnati•4 U.S. locations•View source on ClinicalTrials.gov

Clareo plain-language summary

What this study is about

Generating AI summary...

Save this trial guide to your notes

Keep your clinical trial research organized — questions to ask, what to expect, and key details.

Related studies

RECRUITINGPhase 3

An Adaptive Program of IKT-001 in Pulmonary Arterial Hypertension (PAH)

NCT07365332 · Pulmonary Arterial Hypertension

RECRUITINGPhase 3

A Clinical Study of Sotatercept (MK-7962) in People With Pulmonary Arterial Hypertension (MK-7962-038)

NCT07218029 · Pulmonary Arterial Hypertension

RECRUITINGNA

Comparing Menghini-type Needle and Franseen-type Needle in EBUS-TBNA for Sarcoidosis

NCT06220526 · Suspected Sarcoidosis

RECRUITINGPhase 1/2

A Study to Learn About the Treatment LTP001 in Healthy Participants (Part A) and in Participants With PAH (Part B)

NCT06649110 · Healthy Volunteers, Pulmonary Arterial Hypertension

RECRUITINGNA

Virtual Patient Groups for Sarcoidosis Associated Fatigue

NCT07073963 · Sarcoidosis, Fatigue, and more

View all related studies →

Data from ClinicalTrials.govLast updated on ClinicalTrials.gov: April 12, 2013Terms

Trial snapshot

StatusCOMPLETED

PhasePHASE2/PHASE3

Enrollment43

Start dateApr 2008

Last updatedApr 12, 2013

Condition

Sarcoidosis Pulmonary Arterial Hypertension

Locations shown

Mount Sinai

New York, New York

University of Cincinnati

Cincinnati, Ohio

Cleveland Clinic

Cleveland, Ohio

For caregivers

Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.

Start free trial →

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: April 12, 2013Data synced to Clareo: May 25, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions